US Stock Insider Trading | Penumbra discloses four insider transactions on March 17

K-LinePoet · 2026-04-02T02:55:36+00:00

On March 17, 2026, Penumbra disclosed insider trading activities of its executives, mainly including records of Yuen Maggie and others selling shares on March 15, indicating that company executives frequently engage in stock trading. Penumbra is a global interventional therapy company focused on innovative medical devices.

K-LinePoet

2026-04-02 02:55:36

Abstract generation in progress

On March 17, 2026, Penumbra (PEN) disclosed four company insider transactions. Executive Yuen Maggie sold 186 shares on March 15, 2026.

[Recent Insider Trading]

Disclosure Date	Title	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
March 17, 2026	Executive	Roberts Johanna	March 15, 2026	Sell	186	336.18	62.5k
March 17, 2026	Executive	Shiu Lambert	March 15, 2026	Sell	150	336.18	50.4k
March 17, 2026	Executive	Narayan Shruthi	March 15, 2026	Sell	117	336.18	39.3k
March 17, 2026	Executive	Yuen Maggie	March 15, 2026	Sell	186	336.18	62.5k
March 4, 2026	Executive	Yuen Maggie	March 2, 2026	Sell	2432	342.30	832.5k
February 18, 2026	Executive	Shiu Lambert	February 15, 2026	Sell	412	339.30	139.8k
February 18, 2026	Executive	Yuen Maggie	February 15, 2026	Sell	481	339.30	163.2k
February 18, 2026	Executive	Roberts Johanna	February 15, 2026	Sell	482	339.30	163.5k
February 18, 2026	Executive	Narayan Shruthi	February 15, 2026	Sell	705	339.30	239.2k
January 16, 2026	Executive	Narayan Shruthi	January 15, 2026	Sell	286	350.49	100.2k

[Company Profile]

Penumbra, Inc. was incorporated in Delaware in 2004. The company is a global interventional therapy company focused on designing, developing, manufacturing, and selling innovative medical devices. The company has a broad portfolio of products to address challenging medical conditions and substantial clinical demand spanning two major markets. Its product offerings include ischemic stroke, hemorrhagic stroke, and various peripheral blood vessels that can be treated through thrombosis and embolization procedures.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.